Examining the impact of fatty liver disease in bariatric patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the prevalence and prognostic significance of non-alcoholic fatty liver disease (NAFLD) in patients with a body mass index (BMI) over 35. It involves a prospective non-randomized intervention case control design with 600 bariatric surgery patients and 600 matched control patients who do not undergo surgery. The aim is to understand how fatty liver disease affects outcomes in these individuals. Participants will be monitored for various health outcomes related to their liver condition and obesity.

Why it matters

Who can join: the full rules

Inclusion Criteria case group:

* Age \> 18 years
* BMI \>35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark
* Able to give written informed consent.

Inclusion criteria control group:

* Age \> 18 years
* BMI \>35 kg/m2 with no wish to undergo bariatric surgery.
* Able to give written informed consent.

Exclusion Criteria:

* Active viral hepatitis
* Not willing or able to consent
* Contraindications to liver biopsy

Where it's running

• Hospital of Southwest Jutland
  Esbjerg, Denmark Recruiting

Study contacts

• Principal investigator: Mette M Lauridsen, MD, PhD — Esbjerg Hospital - University Hospital of Southern Denmark
• Study coordinator: Mette M Lauridsen, MD PhD
• Email: mette.enok.munk.lauridsen@rsyd.dk
• Phone: 4579182000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood markers to detect liver scarring in fatty liver disease

  This will test whether blood markers can detect liver scarring in adults with NAFLD or NASH who are having or recently had a liver biopsy.

  Recruiting at 2 sites Roche Diagnostics GmbH · Copenhagen and 1 other locations · NCT06819917

• Endoscopic sleeve gastroplasty for people with obesity and MASH

  This study will test whether endoscopic sleeve gastroplasty plus lifestyle changes helps adults with obesity and MASH lose weight and improve liver health compared with lifestyle changes alone.

  Recruiting at 2 sites Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT06138821

• Using endoscopic ultrasound to assess liver stiffness in patients with fatty liver disease

  This study is testing if a special ultrasound can help find liver damage in people with fatty liver disease who are overweight, comparing it to other methods to see which works best.

  Recruiting at 2 sites Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT05728697

• Understanding liver disease linked to alcohol and metabolic syndrome

  This study is trying to find out what causes liver cancer in people with alcohol-related liver disease and fatty liver disease by looking at their health, diet, and immune system over several years.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Nice · NCT05623150

• Effect of a fibre supplement on children with fatty liver disease

  This study is testing whether a fiber supplement can help children aged 8-17 with fatty liver disease improve their liver health over six months.

  Recruiting Phase 2 McMaster University · Hamilton, Ontario · NCT05480696

• Collecting data to predict cancer risk in at-risk populations

  This study is trying to collect samples and health information from people at higher risk of cancer to see if they can find signs that help predict cancer early on.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT05463796

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.